CN101455738B - 一种治疗湿疹的中药组合物及其制备方法 - Google Patents
一种治疗湿疹的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101455738B CN101455738B CN200910001380XA CN200910001380A CN101455738B CN 101455738 B CN101455738 B CN 101455738B CN 200910001380X A CN200910001380X A CN 200910001380XA CN 200910001380 A CN200910001380 A CN 200910001380A CN 101455738 B CN101455738 B CN 101455738B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- cortex
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 109
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 69
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 241000628997 Flos Species 0.000 claims description 35
- 239000000865 liniment Substances 0.000 claims description 21
- 229940040145 liniment Drugs 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 241001649190 Campsis Species 0.000 claims description 16
- 241000545442 Radix Species 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 241001071795 Gentiana Species 0.000 claims description 8
- 241000245240 Lonicera Species 0.000 claims description 8
- 241000219295 Portulaca Species 0.000 claims description 8
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 208000003251 Pruritus Diseases 0.000 abstract description 32
- 229940079593 drug Drugs 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 2
- 240000002234 Allium sativum Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- NEZONWMXZKDMKF-UHFFFAOYSA-N C.I. Natural Red 20 Chemical compound C1=CC(O)=C2C(=O)C(C(O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-UHFFFAOYSA-N 0.000 abstract 1
- 241001546929 Campsis grandiflora Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000004035 Lithospermum officinale Species 0.000 abstract 1
- 235000011030 Lithospermum officinale Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 235000004611 garlic Nutrition 0.000 abstract 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 73
- 239000008280 blood Substances 0.000 description 72
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 37
- 201000010099 disease Diseases 0.000 description 36
- 230000000694 effects Effects 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 24
- 230000001737 promoting effect Effects 0.000 description 17
- 230000001717 pathogenic effect Effects 0.000 description 16
- 206010040943 Skin Ulcer Diseases 0.000 description 14
- 231100000019 skin ulcer Toxicity 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 244000052769 pathogen Species 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 244000045947 parasite Species 0.000 description 10
- 239000009636 Huang Qi Substances 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 206010063409 Acarodermatitis Diseases 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 241000447727 Scabies Species 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 208000005687 scabies Diseases 0.000 description 7
- 206010040872 skin infection Diseases 0.000 description 7
- 208000002474 Tinea Diseases 0.000 description 6
- 241000130764 Tinea Species 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010048768 Dermatosis Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 201000005404 rubella Diseases 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000006877 Insect Bites and Stings Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000590428 Panacea Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 2
- 229940043234 carbomer-940 Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010053398 Clonic convulsion Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000037377 skin turgor Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗湿疹的中药组合物及其制备方法。内服药物为:丹参10~20份,蛇床子5~15份,地肤子5~20份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~20份,丹皮10~20份,桃仁10~20份,金银花10~20份;外敷药物为:蛇床子10~30份,吴茱萸10~30份,黄柏10~30份,地肤子10~30份,白鲜皮10~30份,龙胆草10~30份,狼毒5~10份,独头大蒜10~30份,马齿苋10~30份,苦参10~30份,丹皮10~30份,紫草10~30份,枯矾10~30份。本发明调脾胃,祛湿痒,且经济实惠,制作方法简单,能取得良好经济效益。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品及其制备方法,特别涉及一种治疗湿疹的中药组合物及其制备方法。
背景技术
湿疹是一种过敏性皮肤病,临床常见。湿疹、皮炎及癣类等皮肤病是常见的多发病,特别是顽固性的湿疹、皮炎等病症多以奇痒为主要症状,反复搔抓又会使皮肤溃破,组织浸润渗出,皮肤肿胀,给患者带来较大的痛苦。
湿疹是由多种内外因素引起的浅层真皮及表皮炎症。病因复杂。一般认为与变态反应有一定关系。临床可分为急性湿疹,亚急性湿疹和慢性湿疹三种。
急性湿疹:皮肤可见密集的对称性小点状斑丘疹或疱疹、水疱、糜烂,渗出淡黄色液体,伴奇痒,寝食不安等。证属湿热风邪蕴于肌腠,留恋不解。
亚急性湿疹:湿疹在急性发作后,红肿及渗出减轻,进入亚急性阶段,可有丘疹及少量丘疱疹,呈黯红色,有鳞屑及轻度浸润。
慢性湿疹:常由急性及亚急性期迁延而成,或自开始炎症即不十分严重,黯红斑上有丘疹,抓痕及鳞屑。患部皮肤肥厚,表面粗糙,呈苔藓样变,有色素沉着或部分色素减退等,病情时轻时重,延续数月或更久。
临床上治疗这些疾病多采用抗过敏、镇静、激素等药物,如皮炎平、达克宁、皮康王、皮炎宁酊等。它们大多为西药配制,对于患病时间较短、症状较轻的患者,这些药物尚有一定的作用。但对于病程较长、病情较重的患者来说,这些药物仅存在暂时的止痒作用,根本无治愈的可能。还有一部份患者在长时间反复用药后会产生一定的耐药性,这时就连止痒作用也会没有了。
中医统称湿疹为“湿毒疮”。病因系饮食失节,嗜酒或过食辛辣腥发动风之品,伤及脾胃,脾失健远,致使湿热内蕴,又外感风湿热邪,内外两邪相搏,充于腠理,浸润肌肤发为本病。或因身体虚弱,脾为湿困,肌肤失养,或因湿热蕴久,耗伤阴血,化燥生风,而致血虚风燥,肌肤甲错。
中医认为,湿疹的内因是脾虚为湿热所困,运化失职;外因是感受湿热之邪,充于腠理。久病则正虚邪恋,脾虚湿困,或血虚生风生燥,风燥郁结,肌肤失荣。西医认为本病病因复杂,一般认为是变态反应所致疾病,可由变态反应、疾病因素、神经功能障碍及内分泌等因素引起。临床上中医治疗分湿热型、血虚风燥型和脾虚湿困型。
以往中医治疗往往忽视全身治疗,而只重视局部治疗,单纯以中药外用熏洗治疗为主,这种方法实践证明效果不佳,症状只可缓解但很容易复发。患者大都反复发作,缠绵难愈,影响生活质量。多数病人虽多方求治,但一般都效果不佳,导致焦虑、抑郁,进而更进一步加重病情,严重影响工作及生活质量。
临床上采用各种熟知中西药或其合剂都未能从根本上解决问题,特别是长期使用某些药物如类固醇类对皮肤乃至全身会产生副作用,结果是治标不治本,得不偿失。临床上也不乏依然用某些中药医治各种皮肤病,但效果也不尽理想。本发明就所针对现在治疗湿疹的药物的疗效均不理想,见效较慢,对人体副作用大,且易反复发作,缠绵难愈的缺点,发明生产一种见效快、副作用小、抑菌性强的药物,以解除患者的痛苦。
发明内容
本发明所要解决的技术问题在于,提供了一种治疗湿疹的中药组合物及其制备方法,针对治疗湿疹药物的疗效均不理想,见效较慢,且易反复,容易产生抗药性的缺点,在传统医学的基础上结合多年临床经验,采用现代加工方法精心研制而成。本发明对原料药品的各有效成分科学配伍,是一种见效快、副作用小、抑菌性强的药物,能有效解除患者的痛苦。
为解决上述技术问题,本发明提供了一种治疗湿疹的中药组合物,由内服和外敷药物组成,所述内服药物中各种原料的重量份数比为:丹参10~20份,蛇床子5~15份,地肤子5~20份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~20份,丹皮10~20份,桃仁10~20份,金银花10~20份;
所述外敷药物中,各种原料的重量份数比为:蛇床子10~30份,吴茱萸10~30份,黄柏10~30份,地肤子10~30份,白鲜皮10~30份,龙胆草10~30份,狼毒5~10份,独头独头大蒜10~30份,马齿苋10~30份,苦参10~30份,丹皮10~30份,紫草10~30份,枯矾10~30份。
所述治疗湿疹的中药组合物,内服药物中各种原料的重量份数比优选为:丹参10~15份,蛇床子5~10份,地肤子5~10份,鸡血藤10~15份,凌霄花10~15份,当归10~15份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比优选为:蛇床子10~20份,吴茱萸10~20份,黄柏10~20份,地肤子10~20份,白鲜皮10~20份,龙胆草10~20份,狼毒5~10份,独头大蒜10~20份,马齿苋10~20份,苦参10~20份,丹皮10~20份,紫草10~20份,枯矾10~20份。
所述治疗湿疹的中药组合物,内服药物中各种原料的重量份数比也可优选为:丹参10~20份,蛇床子10~15份,地肤子10~15份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比也可优选为:蛇床子10~25份,吴茱萸10~25份,黄柏10~25份,地肤子10~25份,白鲜皮10~25份,龙胆草10~25份,狼毒5~10份,独头大蒜10~25份,马齿苋10~25份,苦参10~25份,丹皮10~25份,紫草10~25份,枯矾10~25份。
所述治疗湿疹的中药组合物,内服药物中各种原料的重量份数比还可优选为:丹参10~15份,蛇床子5~15份,地肤子5~15份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比还可优选为:蛇床子15~30份,吴茱萸15~30份,黄柏15~30份,地肤子15~30份,白鲜皮15~30份,龙胆草15~30份,狼毒5~10份,独头大蒜15~30份,马齿苋15~30份,苦参15~30份,丹皮15~30份,紫草15~30份,枯矾15~30份。
所述治疗湿疹的中药组合物,在使用时可以煎汤剂服用时,每日1剂,水煎分两次服,可以每5天为一疗程。
所述治疗湿疹的中药组合物,内服药物剂型可以为片剂或散剂,服用时,可以一天三次,每5天为一疗程。
为解决上述技术问题,本发明又提供了一种治疗湿疹的中药组合物的制备方法,内服药物散剂的制备包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~110目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每3~5克为一瓶或一盒分装。
为解决上述技术问题,本发明还提供了一种治疗湿疹中药组合物的制备方法,外敷药物的制备包括以下步骤:
将所述原料除枯矾外加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸40~50分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱80℃烘干后冷却,与枯矾混和研磨成细粉状;以每袋2~4g分装袋中,即成粉剂中成药。
为解决上述技术问题,本发明再提供了一种所述外敷药物为凝胶剂型,制备的步骤包括:
将所述药物除枯矾外切碎加入到多功能提取罐内,加入重量份数比为3000份的水浸泡30~40分钟,煎煮1.5小时后,取出第一次煎煮液备用;药渣加入重量份数比为3000份的水煎煮1小时后,取出第二次煎煮液,将两次煎煮液合并过滤,滤液减压浓缩至重量份数比为1000份的溶液,静置沉淀24~36小时,吸取上清液,加热至40~50℃后加入重量份数比为2份的羟苯乙酯及研细的枯矾,搅拌均匀,在常压下浓缩成重量份数比为500份的浓缩溶液;将重量份数比为15份的卡波姆-940与重量份数比为3份的聚山梨酯-80及重量份数比为200份的蒸馏水混合,然后将重量份数比为15份的三乙醇胺溶于重量份数比为300份的蒸馏水中,加入前述混合液,搅拌均匀后加入重量份数比的45份的丙二醇,最后与所述重量份数比为500份的浓缩溶液混合,搅拌均匀。
凝胶剂易涂展,易洗除,无油腻感,能吸收组织渗出液,不妨碍皮肤正常功能,不污染衣物,稠度小而有利于药物的释放。缺点是润滑作用较差,易失水和霉变,常需要添加保湿剂和防腐剂。
与现有技术相比教,本技术具有给药方便,药剂易于制造,成本低廉等优点。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。能创造较好的社会价值及经济利益。
具体实施方式
本发明继承祖国的医学遗产,将中华医药发扬光大,利用满山遍野的中草药,资源优势,研制一种特效、安全、方便、价廉、纯天然的中药制剂,用以治疗各种湿疹以及皮肤病,弥补西药毒副作用大,对人身体危害深等缺陷。本发明制备工艺简单,药物原料价格低廉,疗效好,能达到比较好的社会效果及经济利益。
隋代巢元方在《诸病源候论》中记载:“诸久疮者,内热外虚,为风湿所乘,则头面身体皆生疮”。明代陈实功在《外科正宗》补充了饮食不当,内生湿热之病因。《灵枢·决气》中记载:“上焦开发,宣五谷味,熏肤、充身、泽毛,若雾露之溉,是谓气。”《素问·五脏生成篇》说:“肺之合皮毛,其荣毛也。”故肺气虚时则皮肤失去滋养而致干燥无光泽、毛发枯槁,甚则湿疹。从上述论述中可以看出慢性湿疹乃“本虚标实”之证,“本虚”是指肺脾气虚,“标实”是指风、湿、热三邪为患,据此采用“内外同治”之法。内服药以“标本兼治”立法,方中黄芪、丹参,桃仁补气益气固表,托毒生肌利水;鸡血藤,凌霄花活血化淤;当归安神益智;地肤子、蛇床子清热燥湿杀虫;丹皮,金银花刺消肿排脓。诸药合用益气固表生肌以固其“本”,祛风祛湿杀虫、消肿排脓以治其“标”。
桃仁苦,甘,平为血瘀血闭之专药。苦以泄滞血,甘以生新血。《药品化义》:桃仁,味苦能泻血热,体润能滋肠燥。若连皮研碎多用,走肝经,主破蓄血,逐月水,及遍身疼痛,四肢木痹,左半身不遂,左足痛甚者,以其舒经活血行血,有去瘀生新之功,若去皮捣烂少用,入大肠,治血枯便闭,血燥便难,以其濡润凉血和血,有开结通滞之力。
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也。
地肤子性寒,味辛、苦。能清热利湿,祛风止痒。用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒等症。《要药分剂》载:″入肾、膀胱二经。利小便,清湿热。治小便不利,淋病,带下,疝气,风疹,疮毒,疥癣,阴部湿痒。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。
凌霄花一种传统中药材,具有行血去瘀、凉血祛风利湿,清热解毒,味辛酸,性微寒归肝、心包经、功能活血散瘀,凉血祛风。主治月经不调、经闭症瘕、产后乳肿、皮肤瘙痒.《本草衍义补遗》:凌霄花,治血中痛之要药也,且补阴捷甚,盖有守而独行。《南宁市药物志》:有消炎解毒、止血止痛、排脓生肌之功,治红白痢。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;凌霄花,鸡血藤内服是治疗血淤不散,养血化淤活血的良药。
当归其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
黄芪以补虚为主,能补气固表,利尿托毒,排脓,敛疮生肌。用于气血不足、疮疡内陷、脓成不溃或久溃不敛者。黄芪具有很好的托毒生肌的功能,即久不愈合的脓肿化脓生肌。现代医学研究表明,黄芪内含而多种抗菌有效成分,而且能增强机体的免疫功能,因此还能用于预防某些传染病的发生。《本草逢原》载:“黄芪能补五脏诸虚,治脉弦自汗,泻阴火,去肺热,无汗则发,有汗则止。”是增进抵抗力和防御疾病的良药。
丹皮味苦,微寒,能清营分、血分实热,有凉血止血之功。治温病热入营血,迫血妄行。归肝经。功能主治清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。丹皮清热凉血的作用较佳,既能清血分实热,又能治阴虚发热。《本经》载其:“主寒热,中风契从、痉、惊痫邪气,除坚症瘀血留舍肠胃,安五脏,疗痈疮。”
金银花清热散毒,《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣......”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用中医认为,金银花性寒、味甘、气平,具有清热解毒之功效,可以治疗热毒肿疡、痈疽疔疮等症。且兼有宣散作用。金银花清热解毒作用颇强。
中医认为湿热型(急性、亚急性期)湿疹的病因主要是风湿热毒之邪郁于肌肤,湿热搏结,浸淫肌肤而发病。龙胆草、黄柏清泻三焦之湿热;白鲜皮、苦参、马齿苋清止痛散热解毒;枯矾、丹皮收涩敛疮;地肤子,吴茱萸,蛇床子止痒杀虫消炎,狼毒散结止痛杀虫;独头大蒜杀菌祛毒疗疮癣。诸药内外结合,共收清热祛湿、解毒活血消斑、收敛止痒之功。慢性期的主要病机在于病久血虚风燥,肌肤失养,故肥厚皲裂,缠绵不愈。治应养血润燥,除湿止痒。内外同施,标本共治。同时应向病人介绍病情,使病人消除对疾病的恐惧感。饮食方面,宜食富有营养的清淡食物,多食蔬菜、水果,忌食油腻、鱼腥、鸡鸭羊肉等辛辣刺激性食物;居住方面,应保持清洁安静,光线充足,温湿度适宜,经常通风换气,养成良好的起居习惯,急性期忌用热水和刺激性的物品洗涂患处。。
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也。
地肤子性寒,味辛、苦。能清热利湿,祛风止痒。用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒等症。《要药分剂》载:″入肾、膀胱二经。利小便,清湿热。治小便不利,淋病,带下,疝气,风疹,疮毒,疥癣,阴部湿痒。所治疗湿疹的外科良药!
紫草性寒,味甘、咸。归心、肝经。主治凉血,活血,解毒透疹。用于血热毒盛、斑疹紫黑、麻疹不透、疮疡、湿疹、水火烫伤。清热凉血,用于麻疹,热病癍疹,湿疹,尿血,血淋,血痢,疮疡,解丹毒。《本草正义》载:紫草,气味苦寒,而色紫入血,故清理血分之热。古以治脏腑之热结,后人则专治痘疡,而兼疗癍疹,皆凉血清热之正旨。
龙胆草苦,寒。归肝、胆经。主治清热燥湿,泻肝胆火。用于湿热黄疸,阴肿阴痒,带下,强中,湿疹瘙痒。
黄柏清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《中国药典》载黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳。
苦参性苦,寒。归心、肝、胃、大肠、膀胱经清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;常与黄柏结合使用,是治疗湿疹的外用良药。
狼毒辛、苦,平。有毒。主治散结,逐水,止痛,杀虫。用于水气肿胀,淋巴结结核;外用治疥、癣,杀蝇、蛆。狼毒虽然有一定毒性但少量外用却是治疗湿疹的妙药。《本经》载其:主咳逆上气,破积聚,饮食,寒热,水气,恶疮。尤其对慢性湿疹有特效。
枯矾能消痰,燥湿,止泻,止血,解毒,杀虫。治癫痫,喉痹,疚涎壅甚,肝炎,黄疸,黄肿,胃、十二指肠溃疡,子宫脱垂,白带,泻痢,衄血,口舌生疮,疮痔疥癣。《纲目》载:″吐下痰涎饮磷,燥湿解毒,追涎,止血定痛,蚀恶肉,生好肉,治痈疽疔肿,恶疮,癫痫,疸疾,通大小便,口齿眼目诸病,虎犬蛇蝎百虫伤。″
吴茱萸性热,温中,止痛,理气,燥湿,治呕逆吞酸,厥阴头痛,脏寒吐泻,脘腹胀痛,经行腹痛,五更泄泻,高血压症,脚气,疝气,口疮溃疡,齿痛,湿疹。味辛、苦,散寒止痛,入肝、脾、胃、大肠、肾经。外用具有比较明显的止痛与治疗效果。《雷公炮制药性解》:温中,止痛,理气,燥湿。《本经》载:主温中下气,止痛,咳逆寒热,除湿血痹,逐风邪,开腠理,是治疗湿疹外用的良药。
大蒜生辛,热;熟甘,温。入脾、胃、肺经。主治行滞气,暖脾胃,消症积,解毒,杀虫。治饮食积滞,脘腹冷痛,水肿胀满,泄泻,痢疾,疟疾,百日咳,痈疽肿毒,白秃癣疮,蛇虫咬伤。行气消积,杀虫解毒。用于感冒、菌痢、阿米巴痢疾、肠炎、饮食积滞、痈肿疮疡。具有条好的解毒拔毒功效。《本草拾遗》载其:″去水恶瘴气,除风湿,破冷气,烂痃癖,伏邪恶;宣通温补,无以加之;疗疮癣。″独头大蒜是治疗湿疹外用之良药,且价廉易得。
白鲜皮性寒,味苦。主治清热燥湿,祛风解毒。用于湿热疮毒、黄水淋漓、湿疹、疥癣疮癞、风湿热痹、黄疸尿赤。常配合苦参、地肤子等药同用。《本草原始》载其:″治一切疥癞、恶风、疥癣、杨梅、诸疮热毒。″
马齿苋酸,寒。归肝、大肠经。适用于痢疾、清热解毒,凉血止血。用于热毒血痢,痈肿疔疮,湿疹,丹毒,蛇虫咬伤,便血,痔血,崩漏下血。《开宝重定新本草》:“马齿苋,服之长年不白。”《本草经疏》:“长年不白,总言其凉血益血,疾去身轻之功耳。”
丹皮,其味苦而微辛,其气寒而无毒,辛以散结聚,苦寒除血热,入血分,凉血热之要药也。寒热者,阴虚血热之候也。中风瘛疭、痉、惊痫,皆阴虚内热,营血不足之故。热去则血凉,凉则新血生、阴气复,阴气复则火不炎而无因热生风之证矣,故悉主之。痈疮者,热壅血瘀而成也。凉血行血,故疗痈疮。辛能散血,苦能泻热,故能除血分邪气,及症坚瘀血留舍肠胃。
本中药组合物内外兼治,调经养血,标本兼治,内服外敷药物两者相互促进,提高人体自身免疫力,活血化淤,对人体不产生任何副作用,安全有效,能达到祛病强体的目的。
本发明治疗湿疹的中药组合,外敷药剂的制备方法为:选购配方中的药材,除杂质,除枯矾外将药材加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用。滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸45分钟,过滤。将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,研末成细粉状。以每袋3g分袋入塑料袋中,即成粉剂中成药。
药剂用法:治疗湿疹时,取本品6g加入温开水2000毫升坐浴,使药液浸泡病变位20至30分钟,每日一次。每5天一个疗程。
本发明所述治疗湿疹的中药组合物的制备方法,其特征在于,所述外敷药物为凝胶,其制备的步骤包括:
凝胶所用混和剂为:卡波姆-940 15g,丙二醇45g,聚山梨酯-80 3g,羟苯乙酯2g,三乙醇胺15g;
将所述药物除枯矾外切碎加入到多功能提取罐内,加水3000mL浸泡30min,煎煮1.5h,取煎煮液,再加水3000mL煎煮1h,合并煎煮液,滤过,滤液减压浓缩至1000mL,加入澄清剂适量,静置沉淀24h,吸取上清液,加热至40~50℃后加入羟苯乙酯及研细的枯矾,搅拌均匀,常压浓缩至500mL,即得500mL浓缩液;将卡波姆与聚山梨酯-80及200mL蒸馏水混合,三乙醇胺溶于300mL蒸馏水后加入上述混合液,搅匀再加入丙二醇,再与500mL浓缩液混合搅拌均匀,即得凝胶。
凝胶剂易涂展,易洗除,无油腻感,能吸收组织渗出液,不妨碍皮肤正常功能,稠度小而有利于药物的释放,不污染衣物;缺点是润滑作用较差,易失水和霉变,常需要添加保湿剂和防腐剂。
本发明的药效学研究及毒性(以散剂为例)研究如下:
1.皮肤刺激性试验
取家兔剃毛,对该散剂进行诱导和激发接触试验,在24小时和48小时后观察试验家兔,均不见皮肤有红斑及水肿等现象,与阴性对照组无差异。结果表明,该散剂对皮肤反应强度近于零,即无皮肤变态反应。
2.蓄积毒性试验报告
试验方法:选用20只健康小白鼠,雌、雄各10只,剂量设计每5天为一期,每期剂量分别为0.10LD50、0.15LD50、0.22LD50、0.34LD50、0.50LD50,此样品的雌性、雄性小鼠的LD50均为5000m份/k份BW(五个剂量为500、750、1100、1700、2500m份/k份BW)。每5天称体重一次,调整给药量,按0.1ml/10份BW经口灌胃。20天后,动物无死亡情况发生,试验结束,按递增剂量给受试物20天后,雌性、雄性动物均无死亡情况发生。
3.急性毒性试验
以本品临床日用量的200倍给白鼠阴道内投药,观察5日。结果所有动物健存,其活动、饮食、毛发、排泄物未发现异常,未见毒性反应。对白鼠阴道和破损皮肤进行刺激性试验,未见有刺激性反应和其它不良反应。
毒性试验证明,该药未有毒性作用和不良反应,临床应用安全可靠。
实施例1:李某,男,28岁,司机。患者于2周前因食火锅后出现肛门部坠胀不适,并开始感觉肛门部潮湿、瘙痒难忍,影响工作、睡眠,不自觉地用手搔抓致肛门外糜烂、疼痛,伴有口微渴,小便黄,大便干。查体一般情况可,舌质暗红,苔黄腻,脉弦滑。专科检查,肛门外周皮肤出现大片潮红、糜烂,伴有渗出液。经辨证属湿热下注型急性肛门湿疹,使用如下配方治疗:
内服药物为:丹参10g,蛇床子5g,地肤子10g,鸡血藤10g,凌霄花10g,当归10g,黄芪15g,丹皮10g,桃仁10g,金银花15g;
外敷药物为:蛇床子20g,吴茱萸20g,黄柏10g,地肤子20g,白鲜皮20g,龙胆草20g,狼毒5g,独头大蒜20g,马齿苋20g,苦参10g,丹皮20g,紫草20g,枯矾20g。
内服药物与外敷熏洗配合,用药3d后皮肤渗液明显消失,肛门部干燥。5d后患者自诉瘙痒症状消失,经10d后,肛周皮肤恢复正常,自诉无不适。半年后随访无复发。
实施例2:金某,女,37岁,就诊时自诉肛周瘙痒一年余,有湿润感伴有轻微灼痛感。查体见肛周皮肤大片红斑,由于搔抓可见点状糜烂,有渗出,舌红苔黄腻,脉滑数。诊断为肛周湿疹,使用如下配方治疗:
内服药物为:丹参20g,蛇床子10g,地肤子15g,鸡血藤20g,凌霄花20g,当归20g,黄芪15g,丹皮10g,桃仁15g,金银花10g;
外敷药物为:蛇床子25g,吴茱萸25g,黄柏10g,地肤子25g,白鲜皮25g份,龙胆草10g,狼毒5g,独头大蒜25g,马齿苋25g,苦参25g,丹皮10g,紫草25g,枯矾10g。
内服药物与外敷药物配合使用,3d后复诊患者皮损明显好转,无糜烂渗出,仍有轻微瘙痒。继续给治疗5d后临床症状消失,随访1年无复发。
实施例3:李某,男,42岁。患者诉近一年来右小腿瘙痒反复发作,加剧10天。伴食欲不振,大便干。查体:见右小腿前内侧皮肤增厚粗糙,脱屑,色素较深,有明显抓痕。舌边尖红,苔黄腻,脉细数。诊断为:慢性湿疹。用如下配方治疗:
内服药物:为丹参15g,蛇床子15g,地肤子15g,鸡血藤20g,凌霄花10g,当归20g,黄芪10g,丹皮15g,桃仁15g,金银花15g;
外敷药物为:蛇床子15g,吴茱萸20g,黄柏20g,地肤子30g,白鲜皮15g,龙胆草20g,狼毒10g,独头大蒜30g,马齿苋30g,苦参20g,丹皮20g,紫草25g,枯矾25g。
内服药物与外敷药物配合使用,3d后感觉瘙痒明显减轻,5d后明显好转。10d后症状消失,随访1年未复发。
实施例4:秦某,女,25岁,患者自述10天前无明显诱因身起皮疹,瘙痒严重,搔抓后流水,口服酮体芬等药物治疗,未见明显疗效。现患者皮肤瘙痒,心烦失眠,小便黄,大便干。诊查:躯干、四肢散在红斑,水疱,对称分布,境界不清。皮损周围散在抓痕结痂,舌红、苔黄腻,脉弦数。西医诊断:急性湿疹。辨证:湿热并重。治法:清热除湿,凉血解毒。使用如下配方治疗:
内服药物为:丹参20g,蛇床子15g,地肤子15g,鸡血藤20g,凌霄花10g,当归20g,黄芪20g,丹皮20g,桃仁20g,金银花20g;
外敷药物为:蛇床子30g,吴茱萸30g,黄柏10g,地肤子20g,白鲜皮20g,龙胆草20g,狼毒5g,独头大蒜30g,马齿苋30g,苦参30g,丹皮30g,紫草25g,枯矾20g。
内服药物与外敷药物配合使用,2d后瘙痒明显减轻,5d后瘙痒消失,继续使用一个疗程,痊愈。随访半年未复发。
中医认为,湿疹的内因是脾虚为湿热所困,运化失职;光祛表而不注意内因多数会反复发作,缠绵难愈。本组75例患者符合急,慢性湿疹的诊断标准。年龄0~7岁15例,7~18岁13例,18~35岁11例,35~60岁21例,60~80岁15例;发于头面者12例,耳部8例,乳房部5例,脐部7例,阴囊部6例,女阴部5例,肛周部8例,手部13例,小腿部5例,其他部位6例.于停药后3~7天随访。用药5d后显效达92%。共治愈68例,显效5例,无效或效果不明显2例,治愈率达90.7%,总有效率达97.3%。本发明中药制剂一般2d至5d生效,用药5d至10d病症基本消失痊愈。停用后一般无复发。
Claims (8)
1.一种治疗湿疹的中药组合物,其特征在于,由内服药物和外敷药物组成,
所述内服药物中,各种原料的重量份数比为:丹参10~20份,蛇床子5~15份,地肤子5~20份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~20份,丹皮10~20份,桃仁10~20份,金银花10~20份;
所述外敷药物中,各种原料的重量份数比为:蛇床子10~30份,吴茱萸10~30份,黄柏10~30份,地肤子10~30份,白鲜皮10~30份,龙胆草10~30份,狼毒5~10份,独头大蒜10~30份,马齿苋10~30份,苦参10~30份,丹皮10~30份,紫草10~30份,枯矾10~30份。
2.根据权利要求1所述治疗湿疹的中药组合物,其特征在于,所述内服药物中,各种原料的重量份数比为:丹参10~15份,蛇床子5~10份,地肤子5~10份,鸡血藤10~15份,凌霄花10~15份,当归10~15份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比为:蛇床子10~20份,吴茱萸10~20份,黄柏10~20份,地肤子10~20份,白鲜皮10~20份,龙胆草10~20份,狼毒5~10份,独头大蒜10~20份,马齿苋10~20份,苦参10~20份,丹皮10~20份,紫草10~20份,枯矾10~20份。
3.根据权利要求1所述治疗湿疹的中药组合物,其特征在于,所述内服药物中,各种原料的重量份数比为:丹参10~20份,蛇床子10~15份,地肤子10~15份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比为:蛇床子10~25份,吴茱萸10~25份,黄柏10~25份,地肤子10~25份,白鲜皮10~25份,龙胆草10~25份,狼毒5~10份,独头大蒜10~25份,马齿苋10~25份,苦参10~25份,丹皮10~25份,紫草10~25份,枯矾10~25份。
4.根据权利要求1所述治疗湿疹的中药组合物,其特征在于,所述内服药物中,各种原料的重量份数比为:丹参10~15份,蛇床子5~15份,地肤子5~15份,鸡血藤10~20份,凌霄花10~20份,当归10~20份,黄芪10~15份,丹皮10~15份,桃仁10~15份,金银花10~15份;
所述外敷药物中,各种原料的重量份数比为:蛇床子15~30份,吴茱萸15~30份,黄柏15~30份,地肤子15~30份,白鲜皮15~30份,龙胆草15~30份,狼毒5~10份,独头大蒜15~30份,马齿苋15~30份,苦参15~30份,丹皮15~30份,紫草15~30份,枯矾15~30份。
5.根据权利要求1~4中任一项所述治疗湿疹的中药组合物,其特征在于,所述内服药物,在使用时煎汤剂服用,每日1剂,水煎分两次服,每5天为一疗程。
6.根据权利要求1~4中任一项所述治疗湿疹的中药组合物,其特征在于,所述内服药物剂型为片剂或散剂,服用时,一天三次,每5天为一疗程。
7.一种如权利要求1~4中任一项所述治疗湿疹的中药组合物的制备方法,其特征在于,所述内服药物散剂的制备包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~110目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每3~5克为一瓶或一盒分装。
8.一种如权利要求1~4中任一项所述治疗湿疹中药组合物的制备方法,其特征在于,所述外敷药物的制备包括以下步骤:
将所述原料除枯矾外加水浸泡30分钟至1小时,加热煮30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸40~50分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱80℃烘干后冷却,与枯矾混和研磨成细粉状;以每袋2~4g分装袋中,即成粉剂中成药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910001380XA CN101455738B (zh) | 2009-01-05 | 2009-01-05 | 一种治疗湿疹的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910001380XA CN101455738B (zh) | 2009-01-05 | 2009-01-05 | 一种治疗湿疹的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101455738A CN101455738A (zh) | 2009-06-17 |
| CN101455738B true CN101455738B (zh) | 2011-02-09 |
Family
ID=40767037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910001380XA Expired - Fee Related CN101455738B (zh) | 2009-01-05 | 2009-01-05 | 一种治疗湿疹的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101455738B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804166B (zh) * | 2010-05-05 | 2011-07-27 | 余静 | 一种治疗小儿皮炎湿疹的中药组合物 |
| CN102178804B (zh) * | 2011-04-28 | 2012-10-03 | 孔建 | 一种治疗肛周湿疹的中药组合物及其制备方法 |
| CN103041173B (zh) * | 2012-12-31 | 2014-06-18 | 青岛华仁技术孵化器有限公司 | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 |
| CN103446255A (zh) * | 2013-09-04 | 2013-12-18 | 甘肃省蜂业技术推广总站 | 利用蜂胶花粉制备复方足浴液的方法 |
| CN104491629B (zh) * | 2014-11-25 | 2018-01-09 | 哈尔滨医科大学 | 一种治疗肛周湿疹的外用中药组合物及其制备方法 |
| CN105477454A (zh) * | 2016-01-20 | 2016-04-13 | 赵世明 | 一种治疗湿疹的中药组合物 |
| CN105796807A (zh) * | 2016-04-29 | 2016-07-27 | 欧卉 | 一种治疗急性湿疹的外敷药 |
| CN106109659A (zh) * | 2016-07-29 | 2016-11-16 | 苏州科豪生物制品有限公司 | 一种用于治疗湿疹的泡脚汤及其制备方法 |
| CN106138376A (zh) * | 2016-08-16 | 2016-11-23 | 余桂火 | 一种治疗牛皮癣湿疹脚气疮痈的中药制剂及其制备方法 |
| CN106361504A (zh) * | 2016-08-28 | 2017-02-01 | 黄石良 | 一种纸尿裤 |
| CN106377655A (zh) * | 2016-10-16 | 2017-02-08 | 成都兴倍加生物科技有限责任公司 | 一种治疗湿疹的散剂药物及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242201A (zh) * | 1998-07-20 | 2000-01-26 | 徐景信 | 一种治疗牛皮癣的中成药及其制备方法 |
| CN101274093A (zh) * | 2008-05-06 | 2008-10-01 | 广冬云 | 一种治疗真菌性皮肤病的中药 |
-
2009
- 2009-01-05 CN CN200910001380XA patent/CN101455738B/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242201A (zh) * | 1998-07-20 | 2000-01-26 | 徐景信 | 一种治疗牛皮癣的中成药及其制备方法 |
| CN101274093A (zh) * | 2008-05-06 | 2008-10-01 | 广冬云 | 一种治疗真菌性皮肤病的中药 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101455738A (zh) | 2009-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN101496844B (zh) | 一种治疗白癜风的外用制剂及其制备方法 | |
| CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
| CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
| CN101518600B (zh) | 一种治疗细菌或真菌性皮肤病的中药组合物及其制备方法 | |
| CN103041173A (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
| CN104398934A (zh) | 一种用于皮肤瘙痒的中药组合物及其制备方法 | |
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
| CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
| CN102166278A (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
| CN103705751A (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
| CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
| CN104324340A (zh) | 一种治疗跟骨骨质增生的中药制剂及其制备方法 | |
| CN102895610A (zh) | 一种治疗水肿的药物 | |
| CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN106177819A (zh) | 一种用于颈椎病的外用中药组合物、制备方法及其应用 | |
| CN104324350A (zh) | 一种用于慢性结肠炎的中药组合物及其制备方法 | |
| CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
| CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
| CN107213360A (zh) | 一种治疗重型肌无力的中药组合物 | |
| CN105055685A (zh) | 一种治疗冻疮的药膏及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110209 Termination date: 20120105 |